NCT07750886
- Conditions
- Anaplastic Large Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, +22 more
- Locations
-
- Natera, Inc. Austin, Texas, United States
Clinical trial condition
Primary Mediastinal B-cell Lymphoma
Explore clinical trials studying Primary Mediastinal B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
10 public trials
2 recruiting studies
Primary Mediastinal B-cell Lymphoma trial results
NCT02393157
- Conditions
- Burkitt Lymphoma, CD20+ Lymphoblastic Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- New York Medical College Valhalla, New York, United States
Active, not recruiting
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
NCT04911478
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Blood and Marrow Transplant Program Palo Alto, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Baylor Scott & White Research Institute Dallas, Texas, United States
- MD Anderson Caner Center Houston, Texas, United States
NCT01599559
- Conditions
- Primary Mediastinal B-cell Lymphoma
- Locations
-
- Norton Cancer Institute Louisville, Kentucky, United States
- Mayo Clinil Rocheser Rochester, Minnesota, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Centro de Hematologia y Oncologia Pavlovsky Buenos Aires, Argentina
NCT02631044
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Local Institution - 0006 Birmingham, Alabama, United States
- Local Institution - 0007 Duarte, California, United States
- Local Institution - 0010 San Francisco, California, United States
- Local Institution - 0020 Aurora, Colorado, United States
NCT00924326
- Conditions
- Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma, +21 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
NCT01953692
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +27 more
- Locations
-
Not specified
NCT02669017
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +39 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT00944567
- Conditions
- Primary Mediastinal B-cell Lymphoma
- Locations
-
- A.O. SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
- IRCCS Ospedale Oncologico Bari, Italy
- Policlinico S. Orsola Malpighi Bologna, Italy
- Ospedale Oncologico Cagliari, Italy
NCT00558220
- Conditions
- Diffuse Large B-Cell Lymphoma., Follicular Lymphoma Grade III, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University Hospital Brno-Bohunice Brno, Czechia
- Hospital Chomutov Chomutov, Czechia
- Hospital České Budějovice České Budějovice, Czechia
- University Hospital Hradec Králové Hradec Králové, Czechia